Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease

J Biol Inorg Chem. 2022 Aug;27(4-5):405-419. doi: 10.1007/s00775-022-01942-7. Epub 2022 Jun 17.

Abstract

As shown in studies conducted in recent decades, polyoxometalates (POMs), as inorganic metal oxides, have promising biological activities, including antitumor, anti-infectious and anti-Alzheimer's activities, due to their special structures and properties. However, some side effects impede their clinical applications to a certain extent. Compared with unmodified POMs, POM-based inorganic-organic hybrids and POM-based nanocomposite structures show significantly enhanced bioactivity and reduced side effects. In this review, we introduce the biological activities of POMs and their derivatives and highlight the side effects of POMs on normal cells and organisms and their possible mechanisms of action. We then propose a development direction for overcoming their side effects. POMs are expected to constitute a new generation of inorganic metal drugs for the treatment of cancer, infectious diseases, and Alzheimer's disease.Graphical abstract.

Keywords: Alzheimer’s disease; Biological activity; POMs; Cancer; Infectious diseases.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Anions
  • Communicable Diseases*
  • Humans
  • Neoplasms* / drug therapy
  • Polyelectrolytes
  • Tungsten Compounds* / chemistry
  • Tungsten Compounds* / pharmacology
  • Tungsten Compounds* / therapeutic use

Substances

  • Anions
  • Polyelectrolytes
  • Tungsten Compounds
  • polyoxometalate